American journal of translational research
Cure8 research brief
Why This Matters
The paper identifies a potential microbiome–metabolite–PKC pathway by which an herbal formula reduced colonic injury in a rat model of UC; this could point to new targets for research into mucosal repair and microbiome-directed therapies.
Who Should Pay Attention
Researchers, translational scientists, and clinicians interested in IBD mechanisms, microbiome research, and preclinical therapeutic discovery.
Study Snapshot
Story typeResearch paper
Evidence typeResearch paper
Source depthJournal abstract
What To Know
This animal study reports that a traditional Chinese medicine formula (“Shengjiang San modification”) reduced colon injury and inflammation in a DSS-induced ulcerative colitis rat model.
The investigators used metabolomics and 16S rRNA sequencing and linked treatment effects to changes in the PKC signaling pathway, shifts in gut microbiota (including a disrupted lauric acid–Shigella correlation), and correction of several serum metabolites.
The study compared multiple doses and a mesalazine control and found the high-dose herbal formulation had the strongest effect on histology, body weight recovery, the Firmicutes/Bacteroidetes ratio, and metabolite profiles.
These results are preclinical (rat) data using multi-omics methods; they suggest mechanisms worth further study but do not provide clinical evidence that the treatment is safe or effective in people. Do not change or stop any prescribed IBD treatments based on this report.
Keep In Mind
Animal (DSS) model and multi-omics analyses; results are preclinical and do not establish human safety or efficacy.
Source Details
Review the original publication for the complete reporting, methods, and context.
Research paper
Evidence type derived from source or registry metadata.
PublicationAmerican journal of translational research
AuthorsHe Z, Chen P, Li X +1 more
Study typeJournal article
Indexed viaEurope PMC
Source typeResearch paper
PublishedJul 15, 2026, 12:00 AM
Content availableJournal abstract
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.
Chemical characterization of aconite polysaccharide and its ameliorative effect on ulcerative colitis by regulating gut microbiota and THDCA-driven TGR5/cAMP/PKA/NLRP3 pathway.
This research suggests a new, preclinical microbiome- and metabolite-based pathway (APA-1 → THDCA → TGR5/cAMP/PKA → NLRP3) that reduced inflammation in a mouse model of ulcerative colitis, which could guide future...
Callistephus A from Callistephus chinensis Alleviates DSS-Induced Ulcerative Colitis and Gut-liver Axis Disruption by Targeting the JAK2/STAT1 Pathway and Remodeling Gut Microbiota.
The study identifies a plant-derived compound that reduced inflammation and liver injury in a mouse model of ulcerative colitis and ties its effects to both JAK2/STAT1 inhibition and changes in the gut microbiota—two...
Gut commensal Lachnospira eligens alleviates ulcerative colitis by mediating isodeoxycholic acid via the STAT3/NF-κB signaling pathway
The study identifies a specific gut microbe and a bile-acid metabolite that reduced inflammation in a mouse colitis model and implicates STAT3/NF-κB pathways — a potential new avenue for microbiome-based therapeutics for...